The Research and Development Survey (RANDS) is a platform designed for conducting survey question evaluation and statistical research. RANDS is an ongoing series of surveys from probability-sampled commercial survey panels used for methodological research at the National Center for Health Statistics (NCHS). RANDS estimates are generated using an experimental approach that differs from the survey design approaches generally used by NCHS, including possible biases from different response patterns and sampling frames as well as increased variability from lower sample sizes. Use of the RANDS platform allows NCHS to produce more timely data than would be possible using traditional data collection methods. RANDS is not designed to replace NCHS’ higher quality, core data collections. Below are experimental estimates of reduced access to healthcare for three rounds of RANDS during COVID-19. Data collection for the three rounds of RANDS during COVID-19 occurred between June 9, 2020 and July 6, 2020, August 3, 2020 and August 20, 2020, and May 17, 2021 and June 30, 2021. Information needed to interpret these estimates can be found in the Technical Notes. RANDS during COVID-19 included questions about unmet care in the last 2 months during the coronavirus pandemic. Unmet needs for health care are often the result of cost-related barriers. The National Health Interview Survey, conducted by NCHS, is the source for high-quality data to monitor cost-related health care access problems in the United States. For example, in 2018, 7.3% of persons of all ages reported delaying medical care due to cost and 4.8% reported needing medical care but not getting it due to cost in the past year. However, cost is not the only reason someone might delay or not receive needed medical care. As a result of the coronavirus pandemic, people also may not get needed medical care due to cancelled appointments, cutbacks in transportation options, fear of going to the emergency room, or an altruistic desire to not be a burden on the health care system, among other reasons. The Household Pulse Survey (https://www.cdc.gov/nchs/covid19/pulse/reduced-access-to-care.htm), an online survey conducted in response to the COVID-19 pandemic by the Census Bureau in partnership with other federal agencies including NCHS, also reports estimates of reduced access to care during the pandemic (beginning in Phase 1, which started on April 23, 2020). The Household Pulse Survey reports the percentage of adults who delayed medical care in the last 4 weeks or who needed medical care at any time in the last 4 weeks for something other than coronavirus but did not get it because of the pandemic. The experimental estimates on this page are derived from RANDS during COVID-19 and show the percentage of U.S. adults who were unable to receive medical care (including urgent care, surgery, screening tests, ongoing treatment, regular checkups, prescriptions, dental care, vision care, and hearing care) in the last 2 months. Technical Notes: https://www.cdc.gov/nchs/covid19/rands/reduced-access-to-care.htm#limitations
The HCUP Summary Trend Tables include monthly information on hospital utilization derived from the HCUP State Inpatient Databases (SID) and HCUP State Emergency Department Databases (SEDD). Information on emergency department (ED) utilization is dependent on availability of HCUP data; not all HCUP Partners participate in the SEDD. The HCUP Summary Trend Tables include downloadable Microsoft® Excel tables with information on the following topics: Overview of monthly trends in inpatient and emergency department utilization All inpatient encounter types Inpatient stays by priority conditions -COVID-19 -Influenza -Other acute or viral respiratory infection Inpatient encounter type -Normal newborns -Deliveries -Non-elective inpatient stays, admitted through the ED -Non-elective inpatient stays, not admitted through the ED -Elective inpatient stays Inpatient service line -Maternal and neonatal conditions -Mental health and substance use disorders -Injuries -Surgeries -Other medical conditions Emergency department treat-and-release visits Emergency department treat-and-release visits by priority conditions -COVID-19 -Influenza -Other acute or viral respiratory infection Description of the data source, methodology, and clinical criteria
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Dataset name: asppl_dataset_v2.csv
Version: 2.0
Dataset period: 06/07/2018 - 01/14/2022
Dataset Characteristics: Multivalued
Number of Instances: 8118
Number of Attributes: 9
Missing Values: Yes
Area(s): Health and education
Sources:
Virtual Learning Environment of the Brazilian Health System (AVASUS) (Brasil, 2022a);
Brazilian Occupational Classification (CBO) (Brasil, 2022b);
National Registry of Health Establishments (CNES) (Brasil, 2022c);
Brazilian Institute of Geography and Statistics (IBGE) (Brasil, 2022e).
Description: The data contained in the asppl_dataset_v2.csv dataset (see Table 1) originates from participants of the technology-based educational course “Health Care for People Deprived of Freedom.” The course is available on the AVASUS (Brasil, 2022a). This dataset provides elementary data for analyzing the course’s impact and reach and the profile of its participants. In addition, it brings an update of the data presented in work by Valentim et al. (2021).
Table 1: Description of AVASUS dataset features.
Attributes |
Description |
datatype |
Value |
gender |
Gender of the course participant. |
Categorical. |
Feminino / Masculino / Não Informado. (In English, Female, Male or Uninformed) |
course_progress |
Percentage of completion of the course. |
Numerical. |
Range from 0 to 100. |
course_evaluation |
A score given to the course by the participant. |
Numerical. |
0, 1, 2, 3, 4, 5 or NaN. |
evaluation_commentary |
Comment made by the participant about the course. |
Categorical. |
Free text or NaN. |
region |
Brazilian region in which the participant resides. |
Categorical. |
Brazilian region according to IBGE: Norte, Nordeste, Centro-Oeste, Sudeste or Sul (In English North, Northeast, Midwest, Southeast or South). |
CNES |
The CNES code refers to the health establishment where the participant works. |
Numerical. |
CNES Code or NaN. |
health_care_level |
Identification of the health care network level for which the course participant works. |
Categorical. |
“ATENCAO PRIMARIA”, “MEDIA COMPLEXIDADE”, “ALTA COMPLEXIDADE”, and their possible combinations. |
year_enrollment |
Year in which the course participant registered. |
Numerical. |
Year (YYYY). |
CBO |
Participant occupation. |
Categorical. |
Text coded according to the Brazilian Classification of Occupations or “Indivíduo sem afiliação formal.” (In English “Individual without formal affiliation.”) |
Dataset name: prison_syphilis_and_population_brazil.csv
Dataset period: 2017 - 2020
Dataset Characteristics: Multivalued
Number of Instances: 6
Number of Attributes: 13
Missing Values: No
Source:
National Penitentiary Department (DEPEN) (Brasil, 2022d);
Description: The data contained in the prison_syphilis_and_population_brazil.csv dataset (see Table 2) originate from the National Penitentiary Department Information System (SISDEPEN) (Brasil, 2022d). This dataset provides data on the population and prevalence of syphilis in the Brazilian prison system. In addition, it brings a rate that represents the normalized data for purposes of comparison between the populations of each region and Brazil.
Table 2: Description of DEPEN dataset Features.
Attributes |
Description |
datatype |
Value |
Region |
Brazilian region in which the participant resides. In addition, the sum of the regions, which refers to Brazil. |
Categorical. |
Brazil and Brazilian region according to IBGE: North, Northeast, Midwest, Southeast or South. |
syphilis_2017 |
Number of syphilis cases in the prison system in 2017. |
Numerical. |
Number of syphilis cases. |
syphilis_rate_2017 |
Normalized rate of syphilis cases in 2017. |
Numerical. |
Syphilis case rate. |
syphilis_2018 |
Number of syphilis cases in the prison system in 2018. |
Numerical. |
Number of syphilis cases. |
syphilis_rate_2018 |
Normalized rate of syphilis cases in 2018. |
Numerical. |
Syphilis case rate. |
syphilis_2019 |
Number of syphilis cases in the prison system in 2019. |
Numerical. |
Number of syphilis cases. |
syphilis_rate_2019 |
Normalized rate of syphilis cases in 2019. |
Numerical. |
Syphilis case rate. |
syphilis_2020 |
Number of syphilis cases in the prison system in 2020. |
Numerical. |
Number of syphilis cases. |
syphilis_rate_2020 |
Normalized rate of syphilis cases in 2020. |
Numerical. |
Syphilis case rate. |
pop_2017 |
Prison population in 2017. |
Numerical. |
Population number. |
pop_2018 |
Prison population in 2018. |
Numerical. |
Population number. |
pop_2019 |
Prison population in 2019. |
Numerical. |
Population number. |
pop_2020 |
Prison population in 2020. |
Numerical. |
Population number. |
Dataset name: students_cumulative_sum.csv
Dataset period: 2018 - 2020
Dataset Characteristics: Multivalued
Number of Instances: 6
Number of Attributes: 7
Missing Values: No
Source:
Virtual Learning Environment of the Brazilian Health System (AVASUS) (Brasil, 2022a);
Brazilian Institute of Geography and Statistics (IBGE) (Brasil, 2022e).
Description: The data contained in the students_cumulative_sum.csv dataset (see Table 3) originate mainly from AVASUS (Brasil, 2022a). This dataset provides data on the number of students by region and year. In addition, it brings a rate that represents the normalized data for purposes of comparison between the populations of each region and Brazil. We used population data estimated by the IBGE (Brasil, 2022e) to calculate the rate.
Table 3: Description of Students dataset Features.
https://www.archivemarketresearch.com/privacy-policyhttps://www.archivemarketresearch.com/privacy-policy
The global medical database software market is experiencing robust growth, driven by the increasing adoption of electronic health records (EHRs) and the rising need for efficient health information management (HIM) systems. The market, estimated at $15 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 12% from 2025 to 2033, reaching an estimated $45 billion by 2033. This expansion is fueled by several key factors: the increasing digitization of healthcare, the growing demand for data-driven insights to improve patient care and operational efficiency, and the expanding adoption of cloud-based solutions offering scalability and accessibility. Pharmaceutical companies and academic/research institutions are significant drivers, leveraging these systems for drug discovery, clinical trials management, and advanced research initiatives. However, challenges such as data security concerns, high implementation costs, and the need for robust interoperability between different systems pose restraints to market growth. The market is segmented by software type (EHR, HIM) and application (pharmaceutical companies, academic institutions, others), providing diverse opportunities for specialized vendors. Geographic expansion continues, with North America and Europe currently holding significant market share, but growth is anticipated across Asia-Pacific and other regions as healthcare infrastructure modernizes. The competitive landscape is dynamic, with established players like NextGen Healthcare and emerging companies like Pabau and EHR Your Way vying for market share. The success of individual vendors depends on factors including the scalability of their solutions, the depth of their data analytics capabilities, and the strength of their customer support network. The market's trajectory is heavily influenced by government regulations regarding data privacy and interoperability, the ongoing evolution of healthcare technology, and the increasing focus on personalized medicine. Further growth is likely to be seen in areas such as AI-powered diagnostics, predictive analytics, and advanced data visualization tools integrated within medical databases.
According to our latest research, the global Big Data in Healthcare market size reached USD 41.2 billion in 2024, demonstrating robust expansion driven by the increasing adoption of advanced analytics and data-driven decision-making in the healthcare sector. The market is projected to grow at a CAGR of 17.4% from 2025 to 2033, reaching an estimated value of USD 154.1 billion by 2033. This significant growth is primarily attributed to the surging volume of healthcare data, advancements in artificial intelligence and machine learning, and the increasing focus on improving patient outcomes and operational efficiency across healthcare institutions worldwide.
One of the primary growth factors fueling the Big Data in Healthcare market is the exponential rise in healthcare data generation, driven by the widespread adoption of electronic health records (EHRs), wearable devices, and connected medical equipment. As healthcare organizations seek to harness actionable insights from this data deluge, the demand for advanced analytics solutions has surged. The integration of big data analytics enables providers to enhance clinical decision-making, reduce medical errors, and optimize treatment protocols, thereby improving patient care and safety. Furthermore, the growing emphasis on value-based care models has compelled healthcare stakeholders to invest in robust data analytics platforms that can support population health management and evidence-based medicine, further accelerating market expansion.
Another key driver of the Big Data in Healthcare market is the growing need for cost containment and operational efficiency within healthcare organizations. Rising healthcare costs, resource constraints, and the increasing complexity of healthcare delivery have prompted providers and payers to leverage big data analytics to streamline operations, reduce redundancies, and enhance resource allocation. Financial analytics applications, in particular, are witnessing substantial uptake as organizations strive to identify cost-saving opportunities, detect fraudulent claims, and improve revenue cycle management. Additionally, operational analytics solutions are being deployed to optimize supply chain management, workforce planning, and facility utilization, resulting in enhanced productivity and reduced overheads.
The rapid advancement of artificial intelligence (AI), machine learning, and cloud computing technologies has also played a pivotal role in propelling the Big Data in Healthcare market forward. AI-driven analytics platforms are enabling healthcare providers to uncover hidden patterns in patient data, predict disease outbreaks, and personalize treatment plans based on individual patient profiles. The proliferation of cloud-based solutions has further democratized access to advanced analytics tools, allowing even small and medium-sized healthcare organizations to leverage big data capabilities without significant upfront investments in IT infrastructure. This technological evolution is expected to continue driving innovation and adoption across the global healthcare landscape.
From a regional perspective, North America continues to dominate the Big Data in Healthcare market, accounting for the largest revenue share in 2024, followed by Europe and Asia Pacific. The region's leadership is underpinned by robust healthcare IT infrastructure, high adoption rates of electronic health records, and strong government initiatives promoting data interoperability and healthcare digitization. Meanwhile, Asia Pacific is poised for the fastest growth during the forecast period, fueled by rapid healthcare modernization, expanding digital health initiatives, and increasing investments in healthcare analytics by both public and private sectors. As healthcare systems worldwide continue to prioritize data-driven transformation, the market's regional landscape is expected to evolve, with emerging economies playing an increasingly prominent role in shaping future growth trajectories.
https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
According to Cognitive Market Research, the global big data analytics in healthcare market size is USD 30251.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 17.20% from 2024 to 2031.
North America held the major market of more than 40% of the global revenue with a market size of USD 12100.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.4% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 9075.36 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 6957.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.2% from 2024 to 2031.
Latin America's market has more than 5% of the global revenue, with a market size of USD 16.6 million in 2024, and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 605.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.9% from 2024 to 2031.
The hospitals & clinics category held the highest big data analytics in healthcare market revenue share in 2024.
Market Dynamics of Big Data Analytics in Healthcare Market
Key Drivers for Big Data Analytics in Healthcare Market
Growing Use of EMR and EHR to Increase the Demand Globally:
One aspect that has contributed to the widespread implementation of EHR is government backing for their adoption, given their advantages over traditional paper-based health records. Adoption of EHRs benefits ambulatory practices and patients alike because they enhance patient care, facilitate faster access to records, and improve care coordination; increase practice efficiency and reduce costs through reduced paperwork; foster patient participation and transparency; and improve diagnostic and patient outcomes through accurate prescribing. For instance, To safeguard and legitimize digital healthcare data, the Indian government introduced the Digital Information Security in Healthcare Act (DISHA) in March 2019. The purpose of DISHA is to control the creation, gathering, storing, processing, sharing, and ownership of individually identifiable health information and patient health data. (Source: https://www.znetlive.com/blog/digital-information-security-healthcare-act-disha/).
Growing Need to Lower Medical Expenses to Propel Market Growth:
These days, rising operating costs are a problem for many hospitals and health organizations. Medical practices can operate more efficiently thanks to healthcare analytics. Reduced transcribing expenses, less time spent on paperwork, better billing documentation, fewer or no chart pulls, and storage, and better patient outcomes and care can all help cut down on operating expenses. It is said that putting this into practice saves a lot of money. Moreover, hospitals and medical practitioners can reduce unnecessary and excessive spending by utilizing analytical tools. Research has also shown that medical errors can result in billion-dollar expenses, including higher medical malpractice lawsuit costs and additional expenses for patients who require therapy to recover from errors in medicine. In addition, The application of predictive analytics can improve patient care and lower the likelihood of disease in the future. Thus, it is anticipated that the growing demand to lower operating costs in the healthcare sector will contribute to the expansion of big data analytics in healthcare market.
Key Restraint Factor for the Big Data Analytics in Healthcare Market
Rising Concerns About Safety Could Prevent Market Expansion:
The technology creates serious questions about data security and privacy, as well as about issues like fake data creation, the need for real-time protection, and its desire. Some of the current areas that require attention are the remote warehouse, improper identity management, inadequate acquisitions in the information security and systems, human error, networked appliances, and Internet of Things applications. Attempting to get around these problems is extremely difficult for associations. It is anticipated that the growing frequency of data loss incidents and cyberattacks on businesses that store customer data would hinder the industry's ability to grow. Furthermore, it is anticipated that upholding data privacy regulations such as the EU General...
According to our latest research, the global healthcare predictive analytics market size reached USD 13.7 billion in 2024, demonstrating robust momentum driven by increasing data-driven healthcare initiatives and the growing adoption of digital health solutions. The market is expanding at a CAGR of 23.9% and is forecasted to reach USD 110.2 billion by 2033. This remarkable growth is primarily fueled by advancements in artificial intelligence, machine learning, and the pressing need for cost containment and quality improvement in healthcare delivery worldwide.
One of the primary growth factors propelling the healthcare predictive analytics market is the exponential increase in healthcare data generation. With the proliferation of electronic health records (EHRs), wearable devices, and connected medical technologies, healthcare organizations are amassing vast volumes of structured and unstructured data. This data, when harnessed through predictive analytics, enables healthcare providers to forecast patient outcomes, identify high-risk populations, and optimize resource allocation. Furthermore, the integration of predictive analytics into clinical workflows is transforming patient care by enabling early intervention, reducing hospital readmissions, and improving overall population health management. The growing emphasis on personalized medicine and preventive care is further driving demand for advanced analytics solutions that can deliver actionable insights from complex healthcare datasets.
Another significant driver of market growth is the increasing focus on cost reduction and operational efficiency within the healthcare sector. Healthcare systems worldwide are under mounting pressure to control rising costs while maintaining high standards of care. Predictive analytics empowers organizations to identify inefficiencies, predict patient admission rates, and streamline administrative processes. By leveraging predictive models, healthcare providers can anticipate resource needs, reduce unnecessary testing, and minimize avoidable hospitalizations, leading to substantial cost savings. Additionally, payers and pharmaceutical companies are utilizing predictive analytics to enhance risk adjustment, detect fraudulent claims, and optimize clinical trial outcomes, further expanding the market's scope and application.
The adoption of healthcare predictive analytics is also being accelerated by favorable government initiatives and regulatory mandates aimed at improving healthcare quality and patient safety. Governments in developed and emerging economies are investing in health IT infrastructure, promoting interoperability, and incentivizing the use of advanced analytics to drive evidence-based decision-making. The COVID-19 pandemic has further underscored the importance of predictive analytics in healthcare, as organizations leveraged these tools to forecast disease spread, manage resources, and optimize vaccination strategies. As healthcare systems continue to evolve towards value-based care models, the demand for predictive analytics solutions is expected to surge, creating new opportunities for innovation and market expansion.
From a regional perspective, North America currently dominates the healthcare predictive analytics market, accounting for the largest share in 2024, followed by Europe and Asia Pacific. The region's leadership is attributed to the presence of advanced healthcare infrastructure, widespread adoption of EHRs, and significant investments in digital health technologies. However, Asia Pacific is anticipated to witness the highest growth rate over the forecast period, driven by increasing healthcare digitization, rising awareness about the benefits of predictive analytics, and expanding healthcare expenditure in countries such as China, India, and Japan. Emerging markets in Latin America and the Middle East & Africa are also expected to register substantial growth, supported by government initiatives to modernize healthcare systems and improve patient outcomes.
https://fred.stlouisfed.org/legal/#copyright-public-domainhttps://fred.stlouisfed.org/legal/#copyright-public-domain
Graph and download economic data for Gross Output by Industry: Educational Services, Health Care, and Social Assistance: Health Care and Social Assistance (Chain-Type Quantity Index) (GOQIPHCSA) from Q2 2005 to Q1 2025 about social assistance, quantity index, output, chained, health, gross, private industries, education, services, private, industry, rate, and USA.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The rationale for developing the EU HCCD for use in Health Technology Assessment (HTA) across countries is to provide a common dataset of international costs, which can feed into health economic evaluations carried out by transferring economic evaluation analysis and models across countries. Defining a core dataset of costs for use in HTA across countries enables analyses that try to understand the variation in costs within and across countries (taking into account the differences between the healthcare systems and other factors). Additionally, it makes it easier to carry out multi-country studies and to adapt economic evaluation studies from country to country by saving human resources time (and consequently costs) in the task of looking for healthcare costs.
https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
According to Cognitive Market Research, the global healthcare data storage market size is USD 5.4 billion in 2024 and will expand at a compound annual growth rate (CAGR) of 14.3% from 2024 to 2031. Market Dynamics of Healthcare Data Storage Market
Key Drivers for Healthcare Data Storage Market
Increasing amount of healthcare records- Healthcare data storage market is in high demand due to the increasing amount of healthcare data. Electronic health records (EHRs), medical imaging, wearable electronics, and health applications all contribute to the daily deluge of data generated and amassed by healthcare institutions. This data includes a wide range of information, including patients’ medical records, diagnostic pictures, treatment programs, health indicators in real-time, and more. Moreover, healthcare data storage systems are necessary for efficient management of such vast data sets because they can manage high volumes, provide fast retrieval, and keep data secure. Further, state-of-the-art storage systems are required for compliance with data retention and security regulations. Thus, in order to facilitate better patient care and operational efficiency, the ever-increasing volume of healthcare data is driving the use of advanced data storage technologies.
The market is being propelled by the demand for efficient and rapid access to patient data in order to enhance clinical decision-making and patient care.
Key Restraints for Healthcare Data Storage Market
Healthcare data storage market growth is hindered due to the high costs of implementation and upkeep.
The market expansion is being impeded by concerns about data breaches and data accessibility.
Introduction of the Healthcare Data Storage Market
Healthcare data storage describes the infrastructure and procedures put in place to keep and handle massive volumes of patient records safely. Complying with regulatory requirements while ensuring data integrity, confidentiality, and accessibility is essential for healthcare data storage solutions. The rising amount of digital data produced by healthcare companies, the convenience and speed with which cloud storage solutions can be implemented, and the increasing popularity of hybrid data storage solutions are the primary elements propelling the expansion of this market. Security concerns over cloud-based image processing and analytics, however, are limiting the company’s growth. Concerns about the security of cloud-based image processing and analytics are expected to dampen the worldwide healthcare data storage industry. Additionally, advancements in artificial intelligence, big data analytics, and cloud computing have greatly improved the efficiency and capacity of the healthcare data storage market.
United Healthcare Transparency in Coverage Dataset
Unlock the power of healthcare pricing transparency with our comprehensive United Healthcare Transparency in Coverage dataset. This invaluable resource provides unparalleled insights into healthcare costs, enabling data-driven decision-making for insurers, employers, researchers, and policymakers.
Key Features:
Detailed Data Points:
For each of the 76,000 employers, the dataset includes: 1. In-network negotiated rates for covered items and services 2. Historical out-of-network allowed amounts and billed charges 3. Cost-sharing information for specific items and services 4. Pricing data for medical procedures and services across providers, plans, and employers
Use Cases
For Insurers: - Benchmark your rates against competitors - Optimize network design and provider contracting - Develop more competitive and cost-effective insurance products
For Employers: - Make informed decisions about health plan offerings - Negotiate better rates with insurers and providers - Implement cost-saving strategies for employee healthcare
For Researchers: - Conduct in-depth studies on healthcare pricing variations - Analyze the impact of policy changes on healthcare costs - Investigate regional differences in healthcare pricing
For Policymakers: - Develop evidence-based healthcare policies - Monitor the effectiveness of price transparency initiatives - Identify areas for potential cost-saving interventions
Data Delivery
Our flexible data delivery options ensure you receive the information you need in the most convenient format:
Why Choose Our Dataset?
Harness the power of healthcare pricing transparency to drive your business forward. Contact us today to discuss how our United Healthcare Transparency in Coverage dataset can meet your specific needs and unlock valuable insights for your organization.
https://dataintelo.com/privacy-and-policyhttps://dataintelo.com/privacy-and-policy
The global medical publishing market size was valued at approximately USD 12.5 billion in 2023 and is projected to reach around USD 18.4 billion by 2032, growing at a CAGR of 4.5% during the forecast period. The market is experiencing robust growth driven by the increasing demand for online medical content, the proliferation of digital platforms, and the rising need for up-to-date medical information among healthcare professionals and researchers. The surge in medical research activities and the emphasis on evidence-based practice are significant factors propelling the market growth.
The growth of the medical publishing market can be attributed to several key factors, including technological advancements in digital publishing. The shift from traditional print to digital formats has revolutionized the way medical information is disseminated. Online platforms and e-books have made it easier for healthcare professionals, researchers, and students to access the latest medical knowledge and research findings conveniently. Additionally, the increasing use of smartphones and tablets has further fueled the demand for digital medical content, making it accessible on-the-go.
Another major growth driver for the medical publishing market is the expanding volume of medical research and scientific studies being conducted globally. With the rise in healthcare challenges, there is a growing need for continuous research and development in the medical field. This has led to an increase in the publication of medical journals, research articles, and clinical trial data. Academic institutions and research organizations are major contributors to this trend, constantly generating new knowledge and seeking reputable platforms for publication.
The growing emphasis on evidence-based practice in healthcare is also significantly contributing to the market's expansion. Healthcare professionals are increasingly relying on up-to-date, peer-reviewed medical literature to make informed clinical decisions. This trend has bolstered the demand for high-quality medical journals and publications. Moreover, the COVID-19 pandemic has underscored the importance of timely and accurate medical information, further driving the need for reliable medical publishing sources.
From a regional perspective, North America currently dominates the medical publishing market, accounting for the largest share due to the presence of major medical publishers and a high concentration of research institutions. Europe follows closely, with a strong emphasis on medical research and education. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing healthcare investments, expanding academic infrastructure, and a growing focus on medical research. Latin America, the Middle East, and Africa are also emerging markets with significant potential for growth due to improving healthcare systems and rising awareness about medical research.
The medical publishing market is segmented into books, journals, online platforms, and others, with each product type playing a crucial role in disseminating medical knowledge. The books segment continues to hold a significant share in the market, despite the growing preference for digital formats. Medical textbooks, reference books, and specialized publications remain essential resources for medical students, professionals, and researchers. These books provide comprehensive and in-depth coverage of various medical topics, serving as valuable references throughout one's medical career.
The journals segment is another vital component of the medical publishing market, encompassing peer-reviewed medical journals, clinical trial reports, and research articles. The demand for medical journals has surged due to the increasing emphasis on evidence-based practice and the need for up-to-date clinical information. Medical journals serve as the primary medium for publishing groundbreaking research, clinical studies, and expert opinions. The credibility and reliability of peer-reviewed journals make them indispensable resources for healthcare professionals and researchers.
Online platforms have revolutionized the medical publishing industry by providing convenient and instant access to a vast repository of medical information. These platforms include e-books, digital journals, and databases that offer a wealth of medical literature. The shift towards online platforms is driven by the increasing use of digital devices and the need for real-time
https://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
The size of the Healthcare Data Industry market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 16.20% during the forecast period. Data in healthcare signifies all the information that is created or gathered in the healthcare industry. These include patient records, electronic health records, genomic data, health insurance claims, medical images, and all other clinical trial data. All this stands at the back of modern healthcare and could support many critical applications. First and foremost, health data improves patient care. Pattern analysis for patient records is simplified by health care providers in ensuring accurate disease diagnosis and application of personalized treatment plans. Medical field images, such as X-rays and MRIs, are helpful in finding abnormalities and useful in surgical methods. Genomic data insights comprise susceptibility from a genetic view point, which therefore enables coming up with a customised treatment plan for diseases such as cancer. Then, the health information data is very crucial in conducting research and developing new medical knowledge. Researchers analyze epidemiology of diseases by adopting massive datasets, manufacture new drugs and treatments, and analyze effectiveness of health care programs by such datasets. For instance, the medical trials dataset helps in the development of evidence about the safety and efficiency of new treatment options. The health insurance claims dataset can help assess healthcare utilization patterns so as to identify areas in need of improvement. Therefore, health care data also enables administrative and operational functions of health care organizations. EHRs allow easy maintenance of the patient data, enable sound communications among healthcare providers, and minimize errors. Apart from this, analytics on health insurance claims are performed to make possible billing and reimbursement services to ensure the payment of the healthcare provider in the right amount of their rendered service. Further, analytics data could be used for optimization of resource utilization, in identifying potential cost savings, and making health care organizations efficient as a whole. Healthcare information is one of those precious assets that propel innovation, promote better patient outcomes, and support the coherent functioning of the healthcare system. Therefore, improving the quality and efficiency in which care delivery is offered can be achieved through the effective use of healthcare information by healthcare providers, researchers, and administrators for a better state of health among individuals and communities. Recent developments include: March 2022: Microsoft launched Azure Health Data Services in the United States. It is a platform as a service (PAAS) offering designed exclusively to support protected health information (PHI) in the cloud., March 2022: The government of Thailand launched a big data portal for healthcare facilities. The National Reforms Committee on Public Health recently joined hands with 12 government agencies to improve the quality of healthcare services by implementing digital technologies.. Key drivers for this market are: Increase in Demand for Analytics Solutions for Population Health Management, Rise in Need for Business Intelligence to Optimize Health Administration and Strategy; Surge in Adoption of Big Data in the Healthcare Industry. Potential restraints include: Security Concerns Related to Sensitive Patients Medical Data, High Cost of Implementation and Deployment. Notable trends are: Cloud Segment is Expected to Register a High Growth Rate Over the Forecast Period.
The Agency for Healthcare Research and Quality (AHRQ) Patient Safety Indicator 11 (PSI-11) Measure Rates dataset provides information on provider-level measure rates regarding one preventable complication (postoperative respiratory failure) for Medicare fee-for-service discharges. The PSI-11 measure data is solely reported for providers’ information and quality improvement purposes and are not a part of the Deficit Reduction Act (DRA) Hospital-Acquired Condition (HAC) Payment Provision or HAC Reduction Program.
https://dataintelo.com/privacy-and-policyhttps://dataintelo.com/privacy-and-policy
The global healthcare big data analytics market size is projected to achieve a robust growth trajectory, with a valuation of approximately USD 32 billion in 2023. It is anticipated to soar to around USD 115 billion by 2032, reflecting an impressive compound annual growth rate (CAGR) of 15.4%. This remarkable growth can largely be attributed to the increasing demand for efficient data management systems in the healthcare sector, the rising need for data-driven decision-making, and the expanding adoption of analytics in diverse healthcare applications. The integration of artificial intelligence and machine learning in analytics, the emphasis on personalized medicine, and the growing importance of predictive analytics are further propelling the market forward.
One of the key growth drivers in the healthcare big data analytics market is the rising necessity for cost reduction and improved operational efficiency within the healthcare sector. Hospitals and clinics are increasingly recognizing the value of analytics in streamlining processes, reducing waste, and enhancing patient care. By leveraging big data analytics, healthcare providers can gain insights into patient care patterns, optimize resource allocation, and minimize unnecessary expenditures. This drive towards efficiency is further bolstered by government initiatives and policies aimed at improving healthcare delivery and reducing costs, creating a fertile ground for the adoption of advanced analytics solutions.
Another significant factor contributing to the market's expansion is the growing emphasis on personalized and precision medicine. As healthcare providers aim to offer more tailored treatment options, the analysis of vast datasets becomes crucial. Big data analytics facilitates the identification of patterns and trends in patient data, enabling healthcare providers to make informed decisions regarding personalized treatment plans. Moreover, the continuous advancements in genomics and biotechnology are generating immense volumes of data, necessitating robust analytics solutions to derive actionable insights. This trend towards personalized care is expected to drive substantial investments in big data analytics technologies in the coming years.
Additionally, the increasing prevalence of chronic diseases and the aging global population are driving the demand for effective population health management. Big data analytics plays a pivotal role in analyzing population health trends, identifying at-risk individuals, and devising preventive strategies. Governments and healthcare organizations are increasingly focusing on population health analytics to enhance public health outcomes and reduce the burden on healthcare infrastructure. This growing demand for comprehensive population health management solutions is expected to be a significant driving force for the healthcare big data analytics market over the forecast period.
Healthcare Analytics & Medical Analytics are becoming increasingly vital in the pursuit of personalized and precision medicine. By leveraging these analytics, healthcare providers can delve deeper into patient data to uncover insights that inform individualized treatment plans. This approach not only enhances patient outcomes but also optimizes the use of healthcare resources. As the demand for personalized care continues to rise, the role of healthcare analytics in tailoring treatments to individual patient needs is expected to grow exponentially. The integration of advanced analytics tools into healthcare systems is facilitating a shift towards more patient-centric care models, thereby driving the adoption of these technologies across the sector.
The regional outlook for the healthcare big data analytics market shows a diverse growth pattern across different geographies. North America currently holds a significant share of the market, driven by the presence of advanced healthcare infrastructure, a high level of digitalization, and a strong focus on research and development. Europe is also witnessing considerable growth, with countries like Germany and the United Kingdom leading the charge in the adoption of analytics solutions. Meanwhile, the Asia Pacific region is poised to experience the fastest growth, fueled by rapid technological advancements, increasing healthcare investments, and the need to address healthcare challenges in densely populated regions. Latin America and the Middle East & Africa are expected to show steady growth, driven by improving healthcare infrastruct
Sources: Volumes of the Federal Statistical Office; statistics of the National Association of Statutory Health Insurance Physicians (abbr.: KBV); expert advisory board for health care concerted actions (Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen, SVR), annual reports and progress reports. Summaries of social security; statistic reports of the Federal Ministry for Labour and Social Affairs (BMA). Statistic reports about the public health system of the Federal Ministry for Youth, Family, and healthiness. Statistic reports about the statutory health insurance of the Federal Ministry for Labour and Social Affairs (Bundesministerium für Arbeit und Sozialordnung ) and of the Federal Ministry of Health Care (Bundesministerium für Gesundheit)
https://www.globaldata.com/privacy-policy/https://www.globaldata.com/privacy-policy/
Big Data refers to a large amount of data that is being generated around the world at an unprecedented rate. The data set in question is huge in size and complexity, rendering traditional data management techniques inefficient for processing. Big Data analytics deliver actionable insights based on information and raw data, acting as the driving force behind many ongoing waves of digital transformation, including artificial intelligence (AI), data science, and the Internet of Things (IoT). Many major healthcare companies and organizations are turning to a data-driven approach for transforming healthcare research, marketing, and practice. The core for this transformation is healthcare analytics, which will leave a vast impact on the healthcare sector by providing solutions that are automated, cost-effective, and highly efficient.
The healthcare service industry generates data in abundance in the form of physician notes, pathology reports, and so on, but the correct interpretation of this data is critical for providing actionable insights that will lead to better care. The use of predictive analytics can provide healthcare organizations with valuable insights to improve their existing business models and increase their profitability. Along with empowering the provider, analytics will play a crucial role in consumer empowerment by providing them accurate and actionable insights leading to more effective and faster decision-making. Big Data analytics is expected to revolutionize the industry, leading to better health practices. Read More
Healthcare Analytics Market Size 2025-2029
The healthcare analytics market size is forecast to increase by USD 81.28 billion, at a CAGR of 25% between 2024 and 2029.
The market is experiencing significant growth due to several key trends. The integration of big data with healthcare analytics is a major growth factor, enabling healthcare providers to make data-driven decisions and improve patient outcomes.
Another trend is the increasing use of Internet-enabled mobile devices in healthcare services, allowing for remote monitoring and real-time data access. However, data security and privacy concerns remain a challenge, with the need for strong security measures to protect sensitive patient information. These trends are shaping the future of patient engagement and driving growth in the global healthcare analytics market as well.
What will be the Size of the Healthcare Analytics Market During the Forecast Period?
Request Free Sample
The market is experiencing significant growth due to the increasing adoption of digital solutions for improving patient care and reducing treatment costs. Healthcare organizations are leveraging descriptive analytics to gain insights from clinical data, while predictive and prescriptive analytics enable the development of personalized treatment plans and optimal therapeutic strategies. Financial analytics help manage healthcare expenses, ensuring cost-effective patient care. The National Institutes of Health (NIH) and other research institutions are driving innovation in health data analytics, leading to advancements in areas such as patient compliance, medication selection, and disease management. Industry leaders are utilizing artificial intelligence and machine learning to enhance clinical care, outreach, and disease management, ultimately leading to better treatment consistency and optimal outcomes for patients.
How is this Healthcare Analytics Industry segmented and which is the largest segment?
The healthcare analytics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
Component
Services
Software
Hardware
Deployment
On-premise
Cloud-based
Type
Descriptive Analysis
Predictive Analysis
Prescriptive and Diagnostics
Application
Financial Analytics
Clinical Analytics
Operations and Administrative Analytics
Population Health Analytics
End-User
Insurance Company
Government Agencies
Healthcare Providers
Pharmaceutical and Medical Device Companies
Geography
North America
US
Canada
Europe
France
Germany
Italy
UK
APAC
China
India
Japan
South Korea
South America
Middle East and Africa
By Component Insights
The services segment is estimated to witness significant growth during the forecast period. Healthcare analytics services encompass consulting, learning and training, development and integration, hardware maintenance and support, IT management, process management, and software support. The consulting and software support segments are experiencing significant growth due to the increasing demand for advanced healthcare delivery systems and cost-effective models. The healthcare sector's ongoing transition from on-premises to cloud-based software and IT infrastructure deployment is another growth driver. This shift is expected to increase the demand for IT education and training services. End-users of these services range from individual doctor offices to full-service hospitals and multi-location clinics, including large hospitals and tissue and blood processing organizations.
Get a glance at the share of various segments. Request Free Sample
The services segment was valued at USD 6.7 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
APAC is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions, Request Free Sample
The North American market is driven by the increasing demand for secure data access and effective patient information management. The US and Canada are the primary contributors to this market due to their early adoption of advanced technologies, such as machine learning, predictive analytics, and quantum computing, across various industries. These technologies enable the healthcare sector to optimize patient compliance, medication selection, and therapeutic strategies and, ultimately, achieve optimal outcomes. Major companies in this market provide solutions to help healthcare organizations manage and
According to our latest research, the global population health management market size reached USD 34.7 billion in 2024, reflecting a robust expansion driven by technological integration and evolving healthcare needs. The market is expected to grow at a CAGR of 12.8% from 2025 to 2033, reaching a projected value of USD 102.3 billion by 2033. This impressive growth rate is primarily attributed to the increasing prevalence of chronic diseases, the shift toward value-based care models, and the rising adoption of digital health solutions by healthcare providers and payers worldwide. As per our latest research, the market is witnessing a significant transformation, with a strong emphasis on data-driven decision-making and patient-centric care models.
One of the most significant growth factors propelling the population health management market is the surging incidence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory illnesses. As populations age and lifestyle-related health risks escalate globally, healthcare systems are under mounting pressure to deliver more effective and coordinated care. Population health management solutions offer a holistic approach by integrating clinical, financial, and operational data, enabling healthcare stakeholders to identify at-risk populations, implement targeted interventions, and monitor health outcomes in real-time. This proactive approach not only reduces the overall cost of care but also improves patient outcomes, making it a critical component in the transition from fee-for-service to value-based care models.
Another crucial driver for the population health management market is the rapid advancement and adoption of digital health technologies. The proliferation of electronic health records (EHRs), wearable health devices, telemedicine platforms, and artificial intelligence-powered analytics tools has revolutionized how healthcare data is collected, shared, and analyzed. These technologies empower healthcare providers to gain deeper insights into population health trends, personalize care plans, and enhance patient engagement. Furthermore, government initiatives and regulatory mandates supporting interoperability and data sharing are accelerating the adoption of population health management software and services, especially in developed regions. The integration of advanced analytics and machine learning further amplifies the ability to predict disease outbreaks and manage resource allocation efficiently.
A third major growth factor is the increasing focus on preventive healthcare and wellness programs by both public and private sector stakeholders. Employers, insurers, and government bodies are investing heavily in population health management solutions to reduce long-term healthcare expenditures and improve workforce productivity. Preventive health initiatives, such as vaccination programs, health risk assessments, and wellness coaching, are being seamlessly integrated into population health platforms. These efforts are supported by favorable reimbursement policies and incentives for adopting value-based payment models, which reward healthcare organizations for improving population health metrics. As a result, the market is experiencing widespread adoption across various end-user segments, including healthcare providers, payers, employer groups, and government organizations.
From a regional perspective, North America continues to dominate the population health management market, accounting for the largest share in 2024. This dominance is driven by the presence of advanced healthcare infrastructure, high healthcare IT adoption rates, and supportive government policies such as the Affordable Care Act in the United States. Europe follows closely, benefiting from strong regulatory frameworks and increasing investments in digital health transformation. Meanwhile, the Asia Pacific region is emerging as a high-growth market, fueled by rising healthcare expenditure, expanding insurance coverage, and the growing burden of chronic diseases. Latin America and the Middle East & Africa are also witnessing gradual adoption, although challenges such as limited healthcare IT infrastructure and regulatory complexities persist. Overall, the global market landscape is characterized by rapid technological advancements, evolving care delivery models, and a growing emphasis on population health outcomes.
According to our latest research, the global Federated Learning in Healthcare Data market size has reached USD 160.7 million in 2024, with a robust compound annual growth rate (CAGR) of 34.2% anticipated from 2025 to 2033. By 2033, the market is forecasted to reach USD 2.27 billion, driven by increasing demand for privacy-preserving machine learning solutions, advancements in healthcare analytics, and the proliferation of connected medical devices. The key growth driver for this market is the urgent need to leverage distributed data sources for AI model training without compromising patient privacy or regulatory compliance.
The exponential growth of the Federated Learning in Healthcare Data market is fundamentally propelled by the growing adoption of artificial intelligence and machine learning technologies within the healthcare sector. As healthcare organizations collect and generate massive amounts of sensitive patient data, there is a critical need to extract actionable insights while adhering to strict privacy regulations such as HIPAA and GDPR. Federated learning enables collaborative model training across multiple institutions without the need to centralize raw data, thereby reducing privacy risks and data breach vulnerabilities. This technology is particularly valuable in scenarios where data sharing is restricted, yet the benefits of aggregated intelligence are essential for improving clinical outcomes and accelerating medical research.
Another significant growth factor is the rapid digital transformation of healthcare infrastructure worldwide. Hospitals, research institutes, and pharmaceutical companies are increasingly deploying federated learning frameworks to enhance diagnostic accuracy, personalize treatment plans, and streamline drug discovery processes. The proliferation of Internet of Things (IoT) devices and wearable health monitors has further enriched the volume and diversity of healthcare data available for analysis. Federated learning facilitates real-time, decentralized analytics, enabling healthcare providers to harness the full potential of heterogeneous data sources while maintaining data sovereignty and security. This paradigm shift is fostering a new era of collaborative innovation, where institutions can jointly advance medical knowledge without compromising competitive interests or patient confidentiality.
Moreover, the rising prevalence of chronic diseases and the growing emphasis on precision medicine are amplifying the demand for advanced data analytics in healthcare. Federated learning empowers stakeholders to develop robust predictive models that can identify disease patterns, optimize resource allocation, and improve patient outcomes on a global scale. The technology's ability to support continuous model updates and learning from diverse, real-world datasets is particularly advantageous in addressing emerging healthcare challenges such as pandemics and rare diseases. As a result, federated learning is becoming an integral component of modern healthcare ecosystems, driving sustainable growth and innovation across the industry.
From a regional perspective, North America currently dominates the Federated Learning in Healthcare Data market, accounting for the largest revenue share in 2024. This leadership position is attributed to the region's advanced healthcare infrastructure, strong regulatory frameworks, and early adoption of AI-driven technologies. Europe follows closely, benefiting from robust government initiatives to promote digital health and cross-border research collaboration. The Asia Pacific region is poised for the fastest growth over the forecast period, supported by expanding healthcare investments, increasing digital literacy, and a burgeoning population with rising healthcare needs. Latin America and the Middle East & Africa are also witnessing gradual adoption, driven by ongoing efforts to modernize healthcare delivery and address data privacy concerns. Overall, the global market landscape is characterized by dynamic regional trends and a shared commitment to advancing patient-centric, data-driven healthcare solutions.
The Research and Development Survey (RANDS) is a platform designed for conducting survey question evaluation and statistical research. RANDS is an ongoing series of surveys from probability-sampled commercial survey panels used for methodological research at the National Center for Health Statistics (NCHS). RANDS estimates are generated using an experimental approach that differs from the survey design approaches generally used by NCHS, including possible biases from different response patterns and sampling frames as well as increased variability from lower sample sizes. Use of the RANDS platform allows NCHS to produce more timely data than would be possible using traditional data collection methods. RANDS is not designed to replace NCHS’ higher quality, core data collections. Below are experimental estimates of reduced access to healthcare for three rounds of RANDS during COVID-19. Data collection for the three rounds of RANDS during COVID-19 occurred between June 9, 2020 and July 6, 2020, August 3, 2020 and August 20, 2020, and May 17, 2021 and June 30, 2021. Information needed to interpret these estimates can be found in the Technical Notes. RANDS during COVID-19 included questions about unmet care in the last 2 months during the coronavirus pandemic. Unmet needs for health care are often the result of cost-related barriers. The National Health Interview Survey, conducted by NCHS, is the source for high-quality data to monitor cost-related health care access problems in the United States. For example, in 2018, 7.3% of persons of all ages reported delaying medical care due to cost and 4.8% reported needing medical care but not getting it due to cost in the past year. However, cost is not the only reason someone might delay or not receive needed medical care. As a result of the coronavirus pandemic, people also may not get needed medical care due to cancelled appointments, cutbacks in transportation options, fear of going to the emergency room, or an altruistic desire to not be a burden on the health care system, among other reasons. The Household Pulse Survey (https://www.cdc.gov/nchs/covid19/pulse/reduced-access-to-care.htm), an online survey conducted in response to the COVID-19 pandemic by the Census Bureau in partnership with other federal agencies including NCHS, also reports estimates of reduced access to care during the pandemic (beginning in Phase 1, which started on April 23, 2020). The Household Pulse Survey reports the percentage of adults who delayed medical care in the last 4 weeks or who needed medical care at any time in the last 4 weeks for something other than coronavirus but did not get it because of the pandemic. The experimental estimates on this page are derived from RANDS during COVID-19 and show the percentage of U.S. adults who were unable to receive medical care (including urgent care, surgery, screening tests, ongoing treatment, regular checkups, prescriptions, dental care, vision care, and hearing care) in the last 2 months. Technical Notes: https://www.cdc.gov/nchs/covid19/rands/reduced-access-to-care.htm#limitations